GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
SPECX
Price
$29.22
Change
-$1.01 (-3.34%)
Updated
Feb 21 closing price
Net Assets
3.72B
Ad is loading...

GFACX vs SPECX

Header iconGFACX vs SPECX Comparison
Open Charts GFACX vs SPECXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
Alger Spectra A
Price$29.22
Change-$1.01 (-3.34%)
VolumeN/A
Net Assets3.72B
GFACX vs SPECX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. SPECX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and SPECX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. SPECX (3.72B). GFACX (0.00) and SPECX (0.00) have matching dividends . GFACX was incepted earlier than SPECX: GFACX (24 years) vs SPECX (56 years). SPECX is a more actively managed with annual turnover of: 59.63 vs. GFACX (31.00). GFACX has a lower initial minimum investment than SPECX: GFACX (250) vs SPECX (1000). SPECX annual gain was more profitable for investors over the last year : 25.79 vs. GFACX (10.15). GFACX return over 5 years is better than : 32.83 vs. SPECX (20.59).
GFACXSPECXGFACX / SPECX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years56 years-
Gain YTD2.9802.743109%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets304B3.72B8,165%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.1525.7939%
Returns for 3 years17.6948.8536%
Returns for 5 years32.8320.59159%
Returns for 10 years55.6360.8191%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding